...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: RVXOT

Pretty much a shell. It is described as just a company that puts together some funds and looks for a place to invest them. It is confusing though that they have almost the same company name. This confusion has surfaced here before they were listed also.

Share
New Message
Please login to post a reply